Retrieve available abstracts of 13 articles: HTML format
Single Articles
September 2025
WILSON KJ, Muiruri Liomba A, Seydel KB, Banda OK, et al Re-evaluating malarial retinopathy to improve its diagnostic accuracy in
paediatric cerebral malaria: A retrospective study.
PLoS Med. 2025;22:e1004727. PubMedAbstract available
SAITO M, McGready R A need for new tools for prevention of malaria in pregnancy.
PLoS Med. 2025;22:e1004729. PubMedAbstract available
KAKURU A, Kizza J, Aguti M, Adrama H, et al Dihydroartemisinin-piperaquine plus sulfadoxine-pyrimethamine versus either drug
alone for intermittent preventive treatment of malaria in pregnancy: A
double-blind, randomized, controlled phase 3 trial from Uganda.
PLoS Med. 2025;22:e1004582. PubMedAbstract available
August 2025
VANHEER LN, Ramjith J, Mahamar A, Smit MJ, et al The transmission blocking activity of artemisinin-combination, non-artemisinin,
and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual
participant data.
PLoS Med. 2025;22:e1004683. PubMedAbstract available
March 2025
GILDER ME, Saito M, Haohankhunnatham W, Ling CL, et al Submicroscopic malaria in pregnancy and associated adverse pregnancy events: A
case-cohort study of 4,352 women on the Thailand-Myanmar border.
PLoS Med. 2025;22:e1004529. PubMedAbstract available
January 2025
SEIDLEIN LV Roll out and prospects of the malaria vaccine R21/Matrix-M.
PLoS Med. 2025;22:e1004515. PubMedAbstract available
December 2024
GONZALEZ R, Nhampossa T, Figueroa-Romero A, Tchouatieu AM, et al Protecting the most vulnerable: The urgent need to include HIV-exposed children
in malaria chemoprevention strategies.
PLoS Med. 2024;21:e1004498. PubMedAbstract available
September 2024
FADILAH I, Commons RJ, Chau NH, Chu CS, et al Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in
Plasmodium vivax malaria: A systematic review and individual patient data
meta-analysis.
PLoS Med. 2024;21:e1004411. PubMedAbstract available
May 2024
MOUSA A, Cuomo-Dannenburg G, Thompson HA, Chico RM, et al Measuring protective efficacy and quantifying the impact of drug resistance: A
novel malaria chemoprevention trial design and methodology.
PLoS Med. 2024;21:e1004376. PubMedAbstract available
January 2024
PRICE DJ, Nekkab N, Monteiro WM, Villela DAM, et al Tafenoquine following G6PD screening versus primaquine for the treatment of vivax
malaria in Brazil: A cost-effectiveness analysis using a transmission model.
PLoS Med. 2024;21:e1004255. PubMedAbstract available
November 2023
ZAW AS, Win ESS, Yan SW, Thein KS, et al Successful elimination of falciparum malaria following the introduction of
community-based health workers in Eastern Myanmar: A retrospective analysis.
PLoS Med. 2023;20:e1004318. PubMedAbstract available
WATSON JA, Peto TJ, White NJ Rectal artesunate suppositories for the pre-referral treatment of suspected
severe malaria.
PLoS Med. 2023;20:e1004312. PubMedAbstract available
April 2023
SIGNORELL A, Awor P, Okitawutshu J, Tshefu A, et al Correction: Health worker compliance with severe malaria treatment guidelines in
the context of implementing pre-referral rectal artesunate in the Democratic
Republic of the Congo, Nigeria, and Uganda: An operational study.
PLoS Med. 2023;20:e1004234. PubMedAbstract available